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Abstract: Enhancing the effectiveness of colorectal cancer treatm ent is highly desirable.
R adiation-based anticancer therapy— such as proton therapy (PT)— can be used to shrink 
tum ors before subsequent surgical intervention; therefore, im proving the effectiveness of this 
treatm ent is crucial. The addition of noble m etal nanoparticles (N Ps), acting as radiosensitizers, 
increases the PT therapeutic effect. Thus, in this paper, the effect of novel, g old -p latinu m  
nanocauliflow ers (A uPt N Cs) on PT efficiency is determ ined. For this purpose, crystalline, 
6 6 -nm  fancy shaped, bim etallic A u Pt N C s w ere synthesized using green chem istry m ethod. 
Then, physicochemical characterization of the obtained AuPt NCs by transmission electron microscopy 
(TEM ), selected area electron diffraction (SA ED ), energy dispersive X-ray spectroscopy (ED S), 
and UV-Vis spectra m easurem ents w as carried out. Fully characterized A u Pt N Cs w ere placed 
into a cell culture of colon cancer cell lines (H C T116, SW 480, and SW 620) and a norm al colon 
cell line (FH C) and subsequently  subjected to proton irradiation w ith  a total dose of 15 Gy. 
The 3-(4,5-d im ethylthiazol-2-yl)-5-(3-carboxym ethoxyphenyl)-2-(4-su lfophenyl)-2H -tetrazolium  
(M TS) test, perform ed after 18-h incubation of the irradiated cell culture w ith  A uPt N Cs, show ed a 
significant reduction in cancer cell viability  com pared to norm al cells. Thus, the radio-enhancing 
features of A u Pt N C s indicate their potential application for the im provem ent in  effectiveness of 
anticancer proton therapy.
Keyw ords: gold-platinum  nanocauliflowers; radiosensitizers; proton therapy; M TS test; transmission 
electron m icroscopy; green chem istry; gallic acid
1. Introduction
M alignant tum ors are civilization-related diseases that m ore and m ore people suffer from every 
year w orldw ide. A m ong them , colorectal cancer is the third m ost com m on, and this type of cancer 
can be successfully cured at its early stage by surgical treatm ent [1]. Unfortunately, at m ore advanced 
stages, other methods such as radiation or chem otherapy alone or in com bination w ith im munotherapy 
are recommended; however, their effectiveness is still limited [2- 4 ]. Radiation-based anticancer therapy, 
such as proton radiotherapy, can be used in selective cases, especially  before surgery (along w ith  
chem otherapy), to help shrink a tum or and to make it easier to remove or to enhance the effectiveness 
of im m unotherapy [5 ,6] . The application of a proton beam  enables precise irradiation of the tum or 
and, thus, saving norm al tissues [7]. How ever, it is w orth  noting that the m ethod of proton delivery
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(and at the sam e tim e, the precision of irradiation) depends on the region of the Bragg curve that 
is used for tum or irradiation. In  the case of the P lateau region, an  approxim ately  constant value of 
relative biological effectiveness (RBE) =  1.1 is obtained. On the other hand, in the case of a Bragg peak, 
w e get a high, rapidly changing RBE, m aking it d ifficult to determ ine the actual radiation dose [8 ] . 
In this regard, it is h ighly advisable to find a new  tool, w hich  w ill im prove this type of neoad juvant 
therapies. The help com es to us w ith so-called radiosensitizers [9] .
R adiosensitizers, being  low  in  toxicity, significantly im prove the efficiency of radiation-based  
anticancer therapies such as X -ray  radiation-, proton-, or photodynam ic therapy [10- 12]. 
Radiosensitizers are divided into several types: small m olecular chemotherapeutics (e.g., gemcitabine), 
m acrom olecules (m icroRN A  and proteins), or nanoparticles (N Ps) [13] . The aforem entioned 
radiosensitizers are aimed at improving the effectiveness of, e.g., proton therapy (PT), w hile reducing its 
side effects because the radiation dose used in this case can be m uch lower [14]. Currently, the application 
of N Ps, especially noble m etal N Ps, for this purpose is highly prom ising.
N anom edicine deals w ith  the use of sub-m icrom eter m aterials n o t only as radiosensitizers bu t 
also as drug delivery system s or contrast agents in m edicine [15]. It is associated w ith  a num ber 
of undoubted advantages of such nanom aterials, w hich  include their sm all size, large surface area, 
and stability [16,17]. Noble metal N Ps, especially gold nanoparticles (Au NPs), which have fascinating 
abilities, ought to be highlighted in  a special way. Their capacity  for enhancem ent o f photoelectric 
interaction at low er energy levels as w ell as the possibility  of increasing the energy deposited in the 
tum or deserves attention [18]. U nder the influence of the proton beam , A u N Ps (and other high 
atomic num ber NPs) generate reactive oxygen species (ROS) and free radicals w hich are destructive to 
deoxyribonucleic acid (D N A ), causing its breakage and, thus, cell death [12,19- 24]. A  sim ilar effect, 
however w ith different powers, can be seen for other types of noble metal N Ps, e.g., platinum (Pt NPs), 
gadolinium  (Gd NPs), and silver (Ag NPs) [9,12].
The aim of this study was to establish the synthesis of novel, fancy-shaped bim etallic gold-platinum  
nanocauliflowers (AuPt NCs) w ith a highly developed surface area. This is of interest because there is 
limited inform ation about the application of bim etallic NPs to support the effect of proton irradiation. 
A u Pt N Cs w ere prepared using a green chem istry, eco-friendly m ethod, applying gallic acid as a 
"g reen " reducing agent.
In  this paper, w e exam ined the radio-sensitizing effect of bim etallic 66 -nm  A uPt N C s on three 
cancer cell lines w ith different m alignancy: HCT116, SW 480, and SW 620 as well as the normal colon cell 
line FH C. The efficiency of the PT supported by A uPt N Cs w as investigated by a cytotoxicity  
3-(4,5-d im ethylthiazol-2-yl)-5-(3-carboxym ethoxyphenyl)-2-(4-su lfophenyl)-2H -tetrazolium  (M TS) 
assay. Physicochem ical characterization of A uPt N Cs w as also carried out. Transm ission electron 
m icroscopy (TEM ) served to assess the m orphology of the obtained A uPt N C s. The chem ical 
com position of as-prepared A uPt N Cs w as analyzed by  energy dispersive X-ray spectroscopy (ED S). 
Selected area electron diffraction (SA ED ) w as used to exam ine the crystal structure of A u Pt NCs. 
The UV-Vis spectrum  w as also m easured. A n overview  schem e of the investigation procedure is 
presented in Figure 1 .
Figure 1. Overview scheme of the investigation procedure.
2. Results and D iscussion
2.1. Mechanism of AuPt NCs (Gold-Platinum Nanocauliflowers) Synthesis
In  the studies presented, w e obtained g old -p latin u m  N Ps w ith  a novel shape resem bling 
cauliflowers. They w ere prepared by chem ical reduction of gold and platinum  (HAuCl4 and H 2PtCl6, 
respectively) precursors using gallic acid, w hich is both  a reducing agent and a stabilizer preventing 
agglom eration of these N Ps. G allic acid, being an environm entally  friendly "green's reagent, is also 
relatively cheap. Moreover, gallic acid exhibits a broad spectrum of activity w hen it comes to reducing 
various m etal precursors, w hich  allow s it to be uaed in the synthesis o f num erous monomeCallic 
N Ps as w ell as m ulticom ponent nanocom plexes [25- 29]. By controlling the reaction param eters 
(e.g., temperature or polyvinylpyrrolidone addition), it is possible to obtain nanoparticles with various 
sizes f30]. Such reducing properties of gallic acid are due to the fact that it consists of an arom atic 
ring; containing a carbocyl and hydroxyl group. These groups form  chelating rings w ith  m etal ions, 
w hich are oxidized to benzoquinones by  exposure to air or electrophilic ions [31].
The proposed reaction mechanizm  of tire AuPt NCs synthesis is presented in Figure 2 .
A  color change of the solution to brow n w as observed directly  after the addition e f  gallic acid 
to the reaction m ixture containing gold and platinum  precursors. The very  fast form ation of A uPt 
NCs was due to the significant difference in standard redox potentials of the two metal precu rsors [30]. 
TUe individual ions w ere reducod to the corresponding metans according to the reactions presented 
in Figure 2 . In turn, gallic acid w as transform ed into its oxidized form  [32]. This reaction took place 
in tw o steps, w hich  proceed very  quickly  one after the other. In the first step, gallic acid reduced 
gold ions, as they have a higher standard redox potential. Thus, A u N Ps w ere form ed as cores on 
w hich the platinum  nanoparticles (Pt N Ps) could later be deposited. The second stage of A u Pt N C 
synthesis consisted of tw o-stage reduction of platinum  ions— initially to [ P t C y 2- ions and finally to 
m etallic platinum , w hich w as deposited on the nanogold surface. It is w orth noticing that, due to the 
fact that these reactions took place alm ost sim ultaneously, only the final brow n color corresponding 
to A uPt N C s w as observed in  the reaction m ixture. O n the other hand, w e did not observe the 
red color of the solution corresponding to form ation of A u N Ps w ith  a size o f about 20  nm  [33]. 
The form ation of a porous platinum  shell w as ensured by  the addition of excess platinum  precursors 
to the reaction mixture.
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Figure 2. Synthesis mechanism of1 AuPt nanocauliflowers (NCs) using gallic acid.
2.2. Physicochemical Characterization of AuPt NCs
Several techniques were used to fully characterize the obtained AuPt NCs. The morphology, 
chemical composition, and microstructure of AuPt NCs were determined by scanning transmission 
electron microscopy (STEM) with the High-angle annular dark-field detector (HAADF) detector, 
energy dispersive X-ray spectroscopy (EDS) maps, and the SAED patterns taken in the TEM mode 
(Figure 3a-d). Based on the STEM images, the size distribution of AuPt NCs was estimated (Figure 3e).
Reduction of gold and platinum precursors using gallic acid resulted in preparation of 
monodisperse AuPt NCs with an average size of 66 nm (Figure 3e). The size of the gold core 
was estimated to be around 20 nm. The shape of both Au NPs and Pt NPs was spherical. We observed 
that the platinum shell was composed of small, less than 5 nm Pt NPs agglomerated into larger 
nanostructures. On the STEM image (Figure 3a) and corresponding EDS map of AuPt NCs (Figure 3b, 
Figure S1), we noted the presence— in addition to AuPt NCs— of agglomerated Pt NPs consisting of 
smaller, approximately 2 nm Pt NPs without a gold core. These Pt NPs had weaker contrast due to the 
lower Z atomic number of platinum (Z =  78) than gold (Z =  79).
From the SAED pattern, it was found that the obtained AuPt NCs have a crystalline structure 
(sharp diffraction rings with bright spots were observed). The diffraction rings (Figure 3d) could be 
attributed to the (111), (200), (220), and (311) lattice planes of Au and Pt nanocrystals crystalized in the 
face-centered cubic structure [34].
The UV-Vis measurements of AuPt NCs were also carried out (Figure 4 ). We did not detect any 
peak in the analyzed spectral range. Spherical Au NPs should have given an absorption peak in the 
visible light spectrum; however, we did not observe it [35] . This proved that the nanogold core was 
completely covered with Pt NPs, for which there was no absorption peak in the UV-Vis range [36]. 
Absence of any other peaks in this wavelength range indicated a lack of sample contamination.
Progress o f th e  gold  - p la tin u m  n a n o c a u liflo w e rs  synthesis  
using gallic  acid  as red u c in g  a g e n t
Reduction o f gold 
precursors -  
obtaining a gold core
Reduction o f p latinum  
precursors -  creating  
a branched platinum  shell on 
as - prepared gold core
Gold and platinum  
precursors
Figure 3. Morphology of AuPt NCs: (a) scanning transmission electron microscopy (STEM) High-angle 
annular dark-field detector (HAADF) overview image, (b) energy dispersive X-ray spectroscopy 
(EDS) distribution map oe gold (yeUow) and platinum (red) in AuPt NCs, (c) STEM HAADF 
higher magnification image, (d) corresponding selected area electron diffraction (SAED) pattern, 
anti (e) size distribution of AuPt NCs.
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Figure 4. UV-Vis spectrum of AuPt NCs.
2.3. Impact o f JA uPt NCs on Enhancement of the Proton Beam Irradiation Effect for Selected Cell Lines
The changes in  the colon cancer and norm al epithelium  cells' viability  caused by  A uPt NCs 
as w ell as lay AuPe N C -assisted pcoton bream  irradiation w ere determ ined using the M TS assay. 
The description of all the sam ples anafyzed in this experim ent is show n in Table 1.
Firstly, the cytotoxicity of A uPt NCs w as determ ined. For this purpose, different concentrations 
of AuPt NCs w ere used in the cultures w ith cancer or nocmal cells at three different incubation times. 
The obtained results are presented in Figure 5 .
Table 1. Description of the investigated samples.
Sample Name of Sample in the Manuscript
SW480, SW620, HCT116, and FHC cells without addition of AuPt 
nanocauliflowers (NCs) and proton irradiation (controls) Ctrl
Cells cultured with AuPt (NCs) C@AuPt NCs
Cells irradiated by proton beam C@PR+
Cells cultured with AuPt NCs and irradiated by proton beam C@AuPt NCs@PR+
The highest cytotoxicity  of N C s— for all three incubation tim es— w as noticed for the SW 480 
primary cancer cells. This is consistent w ith other reports— SW 480 cells are generally more sensitive to 
some N Ps or drugs than the SW 620 or HCT116 cells [37- 39]. The cytotoxicity of NPs depends not only 
on the metals used but also on their size, shape, or synthesis method [40,41]. Different concentrations of 
AuPt NCs w ere chosen for AuPt NC-assisted proton irradiation: 50 gL/mL for SW 480 and 75 gL/mL for 
SW 620 and HCT116 cells, respectively. These concentrations were considered as not causing a significant 
decrease in viability  of these cells, i.e., less than 15% of cells w ere dead. M oreover, norm al FH C cells 
w ere treated w ith  both A uPt NCs concentrations to reliably com pare the proton irradiation effect on 
the cancer and norm al cells. There w as no difference in cell viability  for the 18 and 24 h incubation 
tim es, so further studies w ere carried out for 18 h of incubation of N Ps w ith  cells. It should be also 
mentioned that before AuPt NCs addition to the cell culture, the num ber of cells in the Burker chamber 
w as counted to ensure approxim ately the sam e N P -cell ratios for all investigated cell lines.
In  the next step, the effectiveness of A u Pt N C -supported proton beam  irradiation w ith  a total 
irradiation dose of 15 G y and 18 h incubation tim e after irradiation w as investigated. The results 
are show n in Figure 6 . The h ighest decrease in cell v iability  (93% ) after irradiation w ith  the proton 
beam  (w ithout the addition of A u Pt N C s) w as observed for the SW 620 cells. In turn, FH C  cells 
w ere less radiosensitive than both types of colon cancer cells, w hich is in line w ith  the literature [42]. 
A u Pt N C -assisted proton beam  therapy turned out to be m ore effective than proton radiotherapy 
w ithout the presence of NPs. It was observed that the addition of AuPt NCs, w ith a concentration w hich 
does not decrease cell viability by more than 15%, to the cell culture, significantly enhances the effect of 
irradiating cells w ith  protons (Figure 6 a-c ) . The highly developed surface o f this type of bim etallic 
NP ensures large contact area of the cells w ith AuPt N C s, w hich results in generation of an increased 
amount of ROS destructive to cancer cells. A similar effect was observed when using porous Pt NPs as 
radiosensitizers in this type of anticancer therapy [43]. In Figure 6, statistically significant differences 
betw een the C @A uPt N C s@PR+ and Ctrl were observed. The addition of AuPt NCs to the cell culture 
follow ed by proton irradiation resulted in a m ortality of approxim ately 16%, 26% , 38% , and 41%  for 
FHC, HCT116, SW 480, and SW 620 cells, respectively Am ong all studied cancer cell lines, the HCT116 
cells are characterized by  the low est sensitivity to A u Pt N C -assisted proton irradiation, w hich  is 
confirm ed by previous reports on  the high m alignance/m etastasis potential of this cell line [44,45]. 
M oreover, there was a significant statistical difference in viability between normal FHC cells and cancer 
cells irradiated w ith  protons and cultured w ith  the sam e concentration of A uPt N C s. The negligible 
influence of this type of com bined therapy on the norm al cells is h ighly desirable from  a therapeutic 
point o f view . The presence of gallic acid, being a stabilizer of A uPt N C s, m ay influence such a 
selective action of this type of therapy on cancer. This com pound has anti-inflam m atory, antiallergic, 
antibacterial, and anticancer properties [32,46,47]. Several studies have show n that gallic acid has a 
selectively toxic effect on cancer cells, w hile saving norm al ones [48- 50]. Im proving the selectivity of 
NPs towards cancer cells is particularly im portant for application of these nanom aterials in the clinic. 
For this purpose, it is desirable to biofunctionalize such N Ps w ith  som e com pounds increasing the 
cellular uptake by cancer cells. In  the literature, there are reports on m odification of nanoparticles 
w ith proteins (e.g., albumin) or tumor-specific antibodies, e.g., anti-Her2/neu or anti-epidermal growth 
factor receptor (EGFR) [51,52].
Figure 5. Cytotoxicity of AuPt NCs against (a) FHC, (b) HCT116, (c) SW480, and (d) SW620 cells 
after 3 ,18, and 24 h of incubation: data were considered significant when * p <  0.05 versus control. 
The concentrations of HCT116, SW480, and SW620 cells considered optimal were marked in red.
Figure 6. Viability of (a) HCT116, (b) SW480, and (c) SW620 cancer cells compared to FHC normal cells 
after the addition of AuPt NCs and proton irradiation of a total dose of 15 Gy combined with AuPt 
NCs: data were; coneidered significant if * p <  0.05 versus control; # p <  0.05—statistically s^nificant 
differences between the respective cancer line and the normal line.
Sum m arizing, the results of our research indicate the h igh application potential of A uPt N Cs in
proton beam  irradiation of hum an cancer. Further progress in this area m ay allow access to an effective 
tool to support also other radiation-based anticancer therapies, e.g., photon- or photodynam ic therapy.
3. M aterials and M ethods
3.1. Reagents and Chemicals
H ydrogen tetrachloroaurate trihydrate (H A uC l4 X 3H 2O ), hydrogen hexachloroplatinate 
hexahydrate (H2PtCl6 X 6H2O), and gallic acid were purchased from Sigm a-Aldrich (Saint Louis, MO, 
USA). Chem ical reagents w ere used w ithout additional purification or m odification.
3.2. AuPt NCs Synthesis
AuPt NCs were synthesized by green chem istry m ethod using gallic acid acting sim ultaneously as 
a stabilizer and reducing agent. One hundred gL of H A uC h and 400 gL of H 2PtCl6 aqueous solutions 
(10-2 M ) w ere m ixed in 17.5 m L distilled  w ater in a round-bottom  flask. The reaction m ixture w as 
heated until boiling  on a m agnetic stirrer (300 rpm ), and then 2 m L of 5 X 10-3  M  freshly prepared 
gallic acid solution w as added. The reaction w as carried out for 30 m in, observing color change of the 
solution from colorless to brow n, w hich indicates the form ation of A uPt NCs.
3.3. TEM Characterization
Scanning transm ission electron m icroscopy (STEM ) com bined w ith  the high-angle annular 
dark-field  detector (H A A D F) w orking in conventional and high-resolution m ode served as a tool 
to evaluate the m orphology of prepared A uPt N Cs. SA ED  patterns w ere taken in  the TEM  m ode. 
A ll these m easurem ents w ere perform ed on an aberration-corrected FEI Titan electron m icroscope 
operating at 300 kV  equipped w ith  an FEG  (field em ission gun) cathode. ED S m appings w ere done 
using a FEI Talos TEM  operating at 200 kV equipped w ith  an FEG  cathode and four in-colum n EDS 
detectors (Super ED S system ) The particle size d istribution w as evaluated based on STEM  im ages 
taken from  different areas of the TEM  grids, w hich  show ed that the m orphology of the A uPt N Cs is 
the same in the whole analyzed sample (Figure S2). The AuPt NCs were measured and analyzed using 
TIA Software. The diameter of about 100 AuPt N Cs w as measured as a distance between the two most 
distant points of these NPs.
3.4. UV-Vis Spectroscopy
The UV-Vis measurements were performed using a UV-2600 instrument from Shimadzu. The resolution 
was chosen to be 1 nm, and the sampling interval was 1. The volume of each sample was 1 mL. The spectral 
range was from 200 nm to 900 nm.
3.5. Cell Culture
Colon cancer cell lines (SW480 and SW62) were obtained due to the courtesy of Prof. Caroline Dive, 
Paterson Institute for C ancer Research, U niversity  of M anchester. H um an colon carcinom a cell 
line H C T116 and fetal colon cell line FH C  (CRL-1831) w ere obtained from  the A m erican Type 
Culture Collection (ATCC, M anassas, VA, U SA ) and m aintained according to the ATCC's instructions. 
H C T116 cells w ere cultured in  M cC oy's 5A  m edium  (Gibco, Paisley, U K). SW 480 and SW 620 cells 
w ere cultured in D M EM  (D ulbecco's m odified eagle m edium ) w ith  h igh glucose (Corning, NY, 
U SA ). FH C  cells w ere cultured in  D M EM /F12 m edium  (Gibco) supplem ented w ith  25 m M  H EPES 
(4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid), 10 ng/m L cholera toxin, 0.005 m g/m L insulin, 
0.005 mg/mL transferrin, and 100 ng/mL hydrocortisone. All media were supplemented w ith 10% fetal 
bovine serum (FBS, Gibco) and ciprofloxacin (10 gg/mL). The cells were cultured by biweekly passages 
in a 37 °C humidified atmosphere w ith 5% CO2 and regularly tested for Mycoplasma sp. contamination.
3.6. Proton Irradiation and Dosimetry
Irradiations w ere perform ed in the C yclotron C entre Bronow ice, Institute of N uclear Physics 
Polish A cadem y of Sciences, Krakow, Poland. The proton therapy system  w as installed in the Centre 
consists of a IBA  proteus C -235 cyclotron (IBA  PT, Louvain-la-N euve, Belgium ) and tw o gantries 
equipped w ith  scanning nozzles. In  pencil beam  scanning (PB S) techniques, a narrow  proton beam  
is deflected in  tw o perpendicular directions, delivering the dose p oint by  point to the w hole target 
volum e. Irradiations w ere perform ed u sing a m onoenergetic field w ith  an energy of 225 M eV  and 
dim ensions of 20 cm  X 20 cm. The cells w ere irradiated at 1.1 cm  w ater equivalent depth w ith a dose 
of 15 Gy. The gantry w as set at 180°, m eaning that the beam  w as directed from the bottom  to the top. 
The preparation of the experim ent included dosim etry m easurem ents perform ed with a M arkus type 
ionization cham ber calibrated in term s of dose absorbed to water. A  radiation dose of 15 G y w as 
experim entally  selected for our research as nontoxic to the cell lines used. A fter proton irradiation, 
each cell line w as incubated for 18 h and then cell viability w as assessed by  M TS assay.
3.7. MTS Viability Assay
C ytotoxic activity  of A uPt N Cs against norm al and cancer cells w as determ ined using 
3-(4,5-d im ethylthiazol-2-yl)-5-(3-carboxym ethoxyphenyl)-2-(4-su lfophenyl)-2H -tetrazolium  (M TS) 
assay (CellTiter 96® A queous O ne Solution C ell Proliferation Assay, Prom ega, M adison, W I). 
Briefly, the cells w ere cultured in flat-bottom  96-w ell plates (Sarstedt, N um brecht, G erm any) at a 
density of 1 X 104/well in DMEM  m edium  containing 10% FBS. After 48 h, 20 gL of AuPt NC solutions 
w ith different concentrations was added to the 100 gL medium  w ith cells, giving a final concentration of 
AuPt NCs in the medium in the range between 5-150  gg/mL. After incubation periods of 3 ,18 , and 24 h, 
20 gL of M TS dye solution was added per well. The quantity of formazan product, directly proportional 
to the num ber of living cells in culture, w as detected by  absorbance m easurem ents at 490 nm  w ith  a 
96-w ell plate reader (Spark® Tecan, M annedorf, Sw itzerland). For further A u Pt N C -assisted proton 
irradiation studies, a m axim um  concentration w hich did not cause a decrease in cell survival by more 
than 15% after 18 h incubation was selected (50 gg/mL for SW 480 and 75 gg/mL for SW 620 and HCT116 
cells). As for the FHC cell line (control), these cells were treated w ith both (50 and 75 gg/mL) AuPt NC 
concentrations allow ing reliable com parison of the effect of proton irradiation on norm al and colon 
cancer cells.
3.8. Statistical Analysis o f Cell Viability Data
The obtained M TS assay results are represented as the m eans ±  SEM  (standard error of the mean). 
The experim ental data w ere analyzed by  one-w ay analysis of variance (ANOVA) follow ed by  post 
hoc Tukey test. p  value <  0.05 w as considered statistically  significant. The data w ere analyzed and 
presented graphically using GraphPad Prism  8 Software.
4. Conclusions
In this work, we have shown a synergistic effect of 66 nm AuPt NCs and proton irradiation towards 
the destruction of colon cancer cells. Synthesized by  green chem istry  and fully characterized by 
physicochemical methods, AuPt NCs showed a highly developed active surface, which allowed them to 
have a larger contact area with the cells. This fact as well as the presence of gallic acid—  having strong 
anticancer properties— in the structure of AuPt NCs gave promising results. AuPt NC-assisted proton 
irradiation proved to be particularly effective in killing cancer cells (especially in SW 480 and SW 620 
colon cancer cells, w here a decrease in survival to approxim ately 6 0 %  w as observed), w hile norm al 
cells w ere only slightly affected (viability  >  80% ). M oreover, the application of green chem istry 
reagents for the production of NPs is favorable for ecology and ensures higher biocom patibility of such 
nanomaterials. Thus, the developm ent of new and the im provement of already known metallic NPs in 
the future m ay contribute to finding the "golden m ean" in the fight against various types of cancers.
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Ag NPs Silver nanoparticles
AuPt NCs Gold-platinum nanocauliflowers
DMEM Dulbecco's modified eagle medium
EDS Energy dispersive X-ray spectroscopy
EGFR Epidermal growth factor receptor
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FEG Field emission gun
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HEPES 4-(2-hydroxyethyl)-1-piperazineethanesulfonic acid
MTS 3-(4,5-dimethylthiazol-2-yl)-5-(3-carboxymethoxyphenyl)-2-(4-sulfophenyl)-2H-tetrazolium
PBS Pencil beam scanning
PT Proton therapy
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ROS Reactive oxygen species
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